FACE-OFF: Low-Risk MDS ASH 2025
Explore real-world outcomes of Luspatercept and second-line ESAs in treating low-risk MDS, revealing promising response rates and treatment insights.   Featured Video
 

2026 Tandem Meetings: What’s the Latest Research in Multiple Myeloma?

Tandem Meetings Recap: T-Cell Efficacy and Safety Updates in Lymphoma

New Career Center Video:  
Learn how to build and strengthen your oncology referral network with expert insights from Tarita Thomas, MD, PhD, MBA, FACRO. Watch Increasing Your Oncology Referral Network now.
Videos Trending


 

Education Alert
The Clock Is Ticking: Diagnostic Strategies for Timely Sepsis Intervention
0.50 CME / CE / ABIM MOC
How can you overcome diagnostic uncertainty with rapid tests and evidence-based strategies for timely sepsis care?

Education Alert
Patients Progressing on an AI ± CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies
0.50 CME / CE / ABIM MOC
Did you know that the prevalence of acquired ESR1 mutations increases after exposure to endocrine therapy?

Education Alert
Endocrine Therapies in ER-Positive/HER2-Negative MBC: Understanding Their Benefits and Limitations to Optimize Treatment Selection
0.50 CME / CE / ABIM MOC
Did you know that approximately 50% of breast cancer patients who have been exposed to an AI over time in the metastatic setting develop an ESR1 mutation?

Education Alert
Navigating Advances in TRK Fusion-Positive Cancers: A Collaborative Journey From Testing to Therapy
0.50 CME / ABIM MOC
Are you regularly testing for TRK fusions in cancers with high fusion frequency?  

Read More Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC

Read More Videos

Watch Now

Watch Now Trending

Read More

Read More